कोशिश गोल्ड - मुक्त
AstraZeneca India
BioSpectrum Asia
|January 2023
appoints Dr Sanjeev Panchal as Country President MD
-
AstraZeneca Pharma India has announced a change in its leadership with the appointment of Dr Sanjeev Panchal as Country President Managing Director MD), with effect from January 1, 2023. Dr Panchal has been with AstraZeneca for 19
यह कहानी BioSpectrum Asia के January 2023 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
BioSpectrum Asia से और कहानियाँ
BioSpectrum Asia
Australia builds tailored heart pump to transform heart failure care
Despite making up half of the 64 million people living with heart failure, patients with this common form have no access to heart pump treatments and are left with only medication or palliative care.
1 min
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Clinical Research Trends 2026: Hybrid DCTs Set for Surge as Innovation Outpaces Regulatory Hurdles
APAC's openness to innovation, combined with its large population and low trial density, creates strong potential for expanding decentralised clinical trials (DCTs), especially for patients with limited trial access. While regulatory diversity and operational challenges will continue to hinder fully decentralised models, the region is expected to adopt more digital technologies in clinical research. As a result, hybrid DCTs will keep gaining traction, and effective management of digitally collected data will remain a central focus for data science teams.
4 mins
BioSpectrum Asia Dec 2025
BioSpectrum Asia
CSL Seqirus to localise advanced influenza vaccine manufacturing in Saudi Arabia
Australia-based CSL Seqirus and Vaccine Industrial Company have signed a Memorandum of Understanding with the Ministry of Health of Saudi Arabia to enhance the biotechnology sector by accessing advanced cellbased seasonal and pandemic influenza vaccines and localising manufacturing in Saudi Arabia.
1 min
BioSpectrum Asia Dec 2025
BioSpectrum Asia
How Sponsors Could Gain Advantage by Embracing Dose Optimisation in Asia by 2026
In 2026, oncology drug development in Asia may move away from the historical maximum tolerated dose (MTD) paradigm toward evidence-based dose optimisation. Sponsors might consider adopting strategies similar to the FDA's Project Optimus, which emphasises selecting doses that balance efficacy and safety rather than relying solely on toxicity thresholds. Doing so could improve patient outcomes and position companies favourably as regulatory expectations evolve.
1 mins
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Fujifilm launches joint research with National Cancer Center in Japan
Fujifilm Corporation has signed a joint research agreement with the National Cancer Center Japan, a Tokyo-based national institution recognised for its leadership in cancer care and research.
1 min
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Monash spinout RAGE Biotech secures $29 M to advance next-generation RNA therapeutics
Australia's Monash University spinout RAGE Biotech has raised $29 million in Series A funding, marking a major step toward translating RNA-based therapeutics for chronic inflammatory disease into the clinic.
1 min
BioSpectrum Asia Dec 2025
BioSpectrum Asia
US advances women's health related to Hormone Replacement Therapy
The US Department of Health and Human Services (HHS) has announced historic action to restore gold-standard science to women's health.
1 min
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Singapore strengthens national blood supply
The Health Sciences Authority (HSA) and Singapore Red Cross (SRC) have launched an enhanced \"Adopt a Bloodbank\" programme and a new Blood Partner Award to forge sustainable partnerships to create a vibrant blood donation scene in Singapore.
1 min
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Health boost for Britain's forces as new NHS programme launches
Thousands of veterans, serving personnel, reservists and their families to receive better healthcare in recognition of their service.
1 min
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Vietnam launches project to accelerate cervical cancer testing
FIND (Foundation for Innovative New Diagnostics), a global health non-profit based in Geneva, Switzerland, has launched a new project in partnership with the Hai Phong Department of Health, Vietnam to develop a copayment mechanism that will expand access to cervical cancer screening across Hai Phong.
1 min
BioSpectrum Asia Dec 2025
Translate
Change font size